Bioactivation of the Pulmonary Toxicants Naphthalene and 1-Nitronaphthalene by Rat CYP2F4

Naphthalene, a ubiquitous environmental contaminant, produces cytotoxicity in nonciliated bronchiolar epithelial (Clara) cells in mice; rats are refractory to lung cytotoxicity from naphthalene. In contrast, 1-nitronaphthalene is a potent toxicant in both species. Naphthalene is metabolized by CYP2F to a 1,2-epoxide, the first and obligate step in events leading to cytotoxicity. 1-Nitronaphthalene is metabolized to both the 5,6- and the 7,8-epoxides with the 7,8-epoxide predominating in lung. Previous studies have demonstrated recombinant CYP2F2 (mouse) to efficiently metabolize both naphthalene and 1-nitronaphthalene. To better understand the mechanism for the unique toxicity profiles for both compounds, a CYP2F ortholog (CYP2F4) was isolated from rat lung and expressed using a baculovirus system. Recombinant CYP2F4 efficiently generates 1R,2S-naphthalene oxide (Km = 3 μM, Vmax = 107 min-1) and the 5,6- and 7,8-epoxides of 1-nitronaphthalene (Km = 18 μM, Vmax = 25 min-1 based on total generated glutathione conjugates). Kinetics and regio/stereoselectivity of rat CYP2F4 were indistinguishable from mouse CYP2F2. These results, combined with our recent immunomapping studies demonstrating minimal pulmonary CYP2F expression in rats, indicate that CYP2F expression is the factor most clearly associated with susceptibility to naphthalene-induced pneumotoxicity. CYP2F4 failed to display an enhanced ability to bioactivate 1-nitronaphthalene, an ability that could have potentially compensated for the lower CYP2F pulmonary expression levels in the rat, yet equal species susceptibilities. These results suggest the importance of other P450 enzymes in the epoxidation/bioactivation of 1-nitronaphthalene. Expression of recombinant CYP2F1 (human) yielded an immunoreactive protein with no detectable CO-difference spectrum suggesting inadequate heme incorporation.

[1]  H. Glatt,et al.  Drug metabolism in man and its relationship to that in three rodent species: monooxygenase, epoxide hydrolase, and glutathione S-transferase activities in subcellular fractions of lung and liver. , 1984, Biochemical medicine.

[2]  D. Morin,et al.  Glutathione conjugation of electrophilic metabolites of 1-nitronaphthalene in rat tracheobronchial airways and liver: identification by mass spectrometry and proton nuclear magnetic resonance spectroscopy. , 1999, Chemical research in toxicology.

[3]  Tetsuo Satoh,et al.  Tissue distribution of mRNA expression of human cytochrome P450 isoforms assessed by high-sensitivity real-time reverse transcription PCR. , 2003, Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan.

[4]  H. Strobel,et al.  Purification and properties of NADPH-cytochrome P-450 reductase. , 1978, Methods in enzymology.

[5]  C. L. Bryan,et al.  Species variation in lung antioxidant enzyme activities. , 1987, Journal of applied physiology.

[6]  F. Farin,et al.  Quantification of multiple human cytochrome P450 mRNA molecules using competitive reverse transcriptase-PCR. , 1998, DNA and cell biology.

[7]  A. Pfeifer,et al.  3-methylindole-induced toxicity to human bronchial epithelial cell lines. , 2003, Toxicological sciences : an official journal of the Society of Toxicology.

[8]  F. Gonzalez,et al.  The CYP2A3 gene product catalyzes coumarin 7-hydroxylation in human liver microsomes. , 1990, Biochemistry.

[9]  R. Baldwin,et al.  Comparison of Pulmonary/Nasal CYP2F Expression Levels in Rodents and Rhesus Macaque , 2004, Journal of Pharmacology and Experimental Therapeutics.

[10]  F. Gonzalez,et al.  Specific dehydrogenation of 3-methylindole and epoxidation of naphthalene by recombinant human CYP2F1 expressed in lymphoblastoid cells. , 1999, Drug metabolism and disposition: the biological fate of chemicals.

[11]  T. Omura,et al.  THE CARBON MONOXIDE-BINDING PIGMENT OF LIVER MICROSOMES. I. EVIDENCE FOR ITS HEMOPROTEIN NATURE. , 1964, The Journal of biological chemistry.

[12]  M. Negishi,et al.  Mouse pulmonary cytochrome P-450 naphthalene hydroxylase: cDNA cloning, sequence, and expression in Saccharomyces cerevisiae. , 1991, Biochemistry.

[13]  A. Scialli,et al.  Principles and methods of toxicology (3rd ed.): Hayes AW, ed. New York, New York: Raven Press; 1994. 1468 pages, $125 , 1995 .

[14]  C. A. Fleschner,et al.  Inhaled naphthalene causes dose dependent Clara cell cytotoxicity in mice but not in rats. , 2001, Toxicology and applied pharmacology.

[15]  S. Nelson,et al.  Stereoselectivity of naphthalene epoxidation by mouse, rat, and hamster pulmonary, hepatic, and renal microsomal enzymes. , 1987, Drug metabolism and disposition: the biological fate of chemicals.

[16]  A. Buckpitt,et al.  Species differences in the regio- and stereoselectivity of 1-nitronaphthalene metabolism. , 2000, Drug metabolism and disposition: the biological fate of chemicals.

[17]  Michigan.,et al.  Toxicological profile for dichloropropenes , 2008 .

[18]  F. Gonzalez,et al.  Metabolism of 3-methylindole by vaccinia-expressed P450 enzymes: correlation of 3-methyleneindolenine formation and protein-binding. , 1996, The Journal of pharmacology and experimental therapeutics.

[19]  G. Carlson,et al.  Benzene metabolism in human lung cell lines BEAS‐2B and A549 and cells overexpressing CYP2F1 , 2004, Journal of biochemical and molecular toxicology.

[20]  Magnus Ingelman-Sundberg,et al.  Polymorphism of cytochrome P450 and xenobiotic toxicity. , 2002, Toxicology.

[21]  R. Rasmussen,et al.  Comparative cytotoxicity of naphthalene and its monomethyl‐ and mononitro‐derivatives in the mouse lung , 1986, Journal of applied toxicology : JAT.

[22]  D. Morin,et al.  Metabolic capabilities of CYP2F2 with various pulmonary toxicants and its relative abundance in mouse lung subcompartments. , 2001, The Journal of pharmacology and experimental therapeutics.

[23]  M. Kitagawa,et al.  CYP2A6*6, a Novel Polymorphism in Cytochrome P450 2A6, Has a Single Amino Acid Substitution (R128Q) That Inactivates Enzymatic Activity* , 2001, The Journal of Biological Chemistry.

[24]  C. Plopper,et al.  Relationship of cytochrome P450 activity to Clara cell cytotoxicity. IV. Metabolism of naphthalene and naphthalene oxide in microdissected airways from mice, rats, and hamsters. , 1995, Molecular pharmacology.

[25]  D. Eastmond,et al.  Evaluation of the potential health effects of the atmospheric reaction products of polycyclic aromatic hydrocarbons. , 1999, Research report.

[26]  Toxicology and Carcinogenesis Studies of Naphthalene (CAS No. 91-20-3) in B6C3F1 Mice (Inhalation Studies). , 1992, National Toxicology Program technical report series.

[27]  D. Dinsdale,et al.  1-Nitronaphthalene toxicity in rat lung and liver: effects of inhibiting and inducing cytochrome P450 activity. , 1993, Toxicology and applied pharmacology.

[28]  J R Gillette,et al.  Isozymes of cytochrome P-450 that metabolize naphthalene in liver and lung of untreated mice. , 1990, Drug metabolism and disposition: the biological fate of chemicals.

[29]  M. Brodie,et al.  Tissue and species differences in enzymes of epoxide metabolism. , 1981, Xenobiotica; the fate of foreign compounds in biological systems.

[30]  Iarc Monographs,et al.  Some traditional herbal medicines, some mycotoxins, naphthalene and styrene. , 2002, IARC monographs on the evaluation of carcinogenic risks to humans.

[31]  D. Morin,et al.  Relationship of cytochrome P-450 activity to Clara cell cytotoxicity. I. Histopathologic comparison of the respiratory tract of mice, rats and hamsters after parenteral administration of naphthalene. , 1992, The Journal of pharmacology and experimental therapeutics.

[32]  D. Brown,et al.  Evidence for cytochrome P-450 mediated metabolism in the bronchiolar damage by naphthalene. , 1982, Chemico-biological interactions.

[33]  H. Wang,et al.  Cloning and expression of CYP2F3, a cytochrome P450 that bioactivates the selective pneumotoxins 3-methylindole and naphthalene. , 1998, Archives of biochemistry and biophysics.

[34]  P. Simons,et al.  Purification of glutathione S-transferases by glutathione-affinity chromatography. , 1981, Methods in enzymology.

[35]  R. Baldwin,et al.  Bioactivation of 1,1-dichloroethylene to its epoxide by CYP2E1 and CYP2F enzymes. , 2004, Drug metabolism and disposition: the biological fate of chemicals.

[36]  J. Hakkola,et al.  Detection of cytochrome P450 gene expression in human placenta in first trimester of pregnancy. , 1996, Biochemical pharmacology.

[37]  M. Eichelbaum,et al.  Functional properties of CYP2D6 1 (wild-type) and CYP2D6 7 (His324Pro) expressed by recombinant baculovirus in insect cells , 1997, Naunyn-Schmiedeberg's Archives of Pharmacology.

[38]  P. Choudary,et al.  Role of murine cytochrome P-450 2F2 in metabolic activation of naphthalene and metabolism of other xenobiotics. , 1999, The Journal of pharmacology and experimental therapeutics.

[39]  D. Morin,et al.  Relationship of cytochrome P450 activity to Clara cell cytotoxicity. II. Comparison of stereoselectivity of naphthalene epoxidation in lung and nasal mucosa of mouse, hamster, rat and rhesus monkey. , 1992, The Journal of pharmacology and experimental therapeutics.

[40]  R. Eversole,et al.  An ultrastructural evaluation of acute 1-nitronaphthalene induced hepatic and pulmonary toxicity in the rat. , 1997, Toxicology letters.

[41]  Toxicology and carcinogenesis studies of naphthalene (cas no. 91-20-3) in F344/N rats (inhalation studies). , 2000, National Toxicology Program technical report series.